Sinusoidal obstruction syndrome
Sinusoidal obstruction syndrome (SOS), also known as veno-occlusive disease (VOD), is a condition characterized by damage to the sinusoidal endothelial cells in the liver. This damage leads to the obstruction of the small veins in the liver, causing a range of symptoms and complications.
Pathophysiology[edit | edit source]
The primary mechanism of SOS involves injury to the endothelial cells lining the hepatic sinusoids. This injury can be caused by various factors, including chemotherapy, radiation therapy, and certain toxins. The damaged endothelial cells become swollen and detached, leading to the obstruction of the sinusoids and small hepatic veins. This obstruction results in impaired blood flow through the liver, causing increased pressure in the liver's blood vessels and subsequent liver dysfunction.
Causes[edit | edit source]
SOS is most commonly associated with high-dose chemotherapy and hematopoietic stem cell transplantation (HSCT). Other potential causes include exposure to certain toxins such as pyrrolizidine alkaloids found in some herbal remedies, and radiation therapy to the liver.
Symptoms[edit | edit source]
The symptoms of SOS can vary in severity and may include:
- Hepatomegaly (enlarged liver)
- Jaundice (yellowing of the skin and eyes)
- Ascites (accumulation of fluid in the abdomen)
- Weight gain due to fluid retention
- Right upper quadrant pain
Diagnosis[edit | edit source]
The diagnosis of SOS is based on clinical criteria, laboratory tests, and imaging studies. Key diagnostic criteria include:
- Rapid weight gain
- Painful hepatomegaly
- Elevated levels of bilirubin in the blood
Imaging studies such as ultrasound or CT scan may show signs of liver enlargement and ascites.
Treatment[edit | edit source]
The management of SOS involves supportive care and addressing the underlying cause. Treatment options may include:
- Diuretics to manage fluid retention
- Analgesics for pain relief
- Defibrotide, a medication that has been shown to improve outcomes in patients with severe SOS
Prognosis[edit | edit source]
The prognosis of SOS depends on the severity of the condition and the underlying cause. Mild cases may resolve with supportive care, while severe cases can lead to significant liver dysfunction and may be life-threatening.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD